FDA is taking steps towards requiring electronic submission of certain safety reports under an investigational new drug (IND) application into the FDA's Adverse Event Reporting System (FAERS).
Read more: Digital submission of adverse event reports for investigational new drug applications reflects FDA’s ongoing modernization efforts